IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: Dustyslay, 25 Jun 2024 08:33
Last post: GIVMESUNSHINE, Today 01:52
Kong
You mistake my posts as speculation over facts
All I'm doing is highlighting info from RnS and presentation.I haven't made this stuff up - whether is continues or falters is up for debate
Cirt is currently processing 4.25 a day June (so far )
PSE - Avwraging 3.25 a day over q2 (not linear, started Q2 @ about 40 per month )
So what's up for discussion is the relevance of these, taking into account the good recent news , but with a strong Hangover from lessons learned .we can all speculate on that till the cows come home ...I personally think the information within the recent RNS / trials / presentation can only add to those numbers, but may be wrong - happy to debate .. just can't deal with binary 1500 or bust, fundraise next month cr"p .
Long long way to go. I have no doubt about it, but at least from a stand point I know the tasks ahead.
I'm not under any over expectancy issues, and not investing into anything as such.
I'm not encouraging buying, I certainly won't be from here.
5p buy was albeit a gamble, it was a calculated one at best. That up until now has paid dividend.
I'm not writing this off yet, but will accept if it doesn't progress I will assess the risk.
Agree it is a positive
But it is a long way to go
And many bridges have to be crossed before you get to the gates
That's all we can do, but as our conversations about our presentation with a consortium of NHS trusts to apply the CIRRP, a lot can happen in between.
That's a positive, whatever way you spin it.
And it was a topic worthy of discussion regardless of the ongoing problems
Dusty
We can only wait until next trading statement to see how Burrows and Oxford are doing.
Apparent givemesunshine mentioned that Oxford were selling over 4 tests a day now.
Let’s see where we are on next RNS
Good luck
Kong
Started: Dustyslay, 28 Jun 2024 16:34
Last post: Dustyslay, 28 Jun 2024 16:34
300.000 at 6.3p?
Started: GIVMESUNSHINE, 24 Jun 2024 16:56
Last post: Dustyslay, 24 Jun 2024 22:17
If we win it, and it's Met with a decent amount of fanfare I may push for a 10p average.
See how it goes, what the market says
Says 3 days, but as most things probably won't see anything positive from it to start taking effect for a few weeks although it may be a big enough signal to get things moving in the right direction.
4.5mill first payment will be kind to us now.
But if it reflects sp performance in this period is 50/50
This trial will be almost with almost all the leg work being done by OBD, tests and use of the UK Labs - Obd will be highly involved - there is no trial without 9BD by the looks of it -spend of £4mil in the first year ( if max awarded) I'm asumeomg it will be cost+ reimbursement which will bring in some decent revenue - but that remains to be seen - need to win it first I suppose .. I think though it emphasises what's been going on in the background.. I think there was a lesson learned there and not even mentioned it until H1 .. more importantly is that the trial is imbedded within 2 NHS trusts, data building .. I won't post anymore on it as it's pointless unless it's confirmed , but it's not a year away it's imminent
So was I,I was at 32p till our death date last week.
I bought a chunk at 5.2p as it fell off a cliff expecting a pull back straight away, but as the dust settled its become worth holding out
Dustyslay.
Unfortunately I am much higher than your 12p and I surely wouldn’t be selling at 9p. I believe we will be rewarded by the end of the year if not Q1 25.
Patience will pay dividends.
GLA LTHs
Started: Pensioninvestor, 24 Jun 2024 09:22
Last post: Dustyslay, 24 Jun 2024 16:55
TBH I never really thought too much into him, only really the narrative from the board.
When the sp performance was outstanding, I'm not sure he correlated that market sentiment to consumer sales and got too far ahead of himself.
Was he lying, which I've found myself saying now, or was it naive exhubberence from an idiot.
The wages seem excessive, and obviously his daughter on marketing with sales not being what was portrayed didn't mark that acquisition in a great light.
But he has done good things, and for a while was ceo of the year!!!
So I just try to move past it now, everything is in place for this to be successful, if the new shares issued is how they say incentives driven then we should expect progress.
But nothing is assured, so we as investors can debate the plan set out and follow it's traction closely in hope this rotten egg, becomes the golden goose we imagined less than a year ago.
When I had a 32p avg, now it's 12p so if it can it could be worth the pain in the end
Im more looking at the FD TBH, Jon is being judged too early IMO (but the warning signs are there ) to use the Football link again -your only as good as you last result - everyone was up his ~rse when the SP 4 folded 😂
He is as bad as it gets, but....
Sometimes the product and the science finds a way regardless
Well done Burrows for causing such division among investors. Great way to run a company.
I haven't posted I'm avdfn for those reasons, it's not for me I'd cope 5 mins and remove myself.
I think we can achieve a good deal here with a respectful mindset, my mind has been stretched a great deal on lse lately so its reflected on my posts here.
I'll come back fresher, I do see positive feedback, but it's hard to be blind to the shortcomings so far.
We was lied to and that still weighs heavily, but I see buys so I'll have a bit more confidence once I take time to go over the latest reports with more emphasis
Started: thewombat, 21 Jun 2024 19:02
Last post: Newuncle, 24 Jun 2024 09:11
Thewombat,
Sorry about that....of course you are right and I wish you well here.
@Newuncle. I put zero value on the kind of condescending response you made to me. If that is, truly, the best you can do, perhaps not commenting would be a better course of action. It adds noting to the discussion.
I think we can all agree we know where we stand, 9p for me would be good 👍
If its starts making progress next week I could potentially add 10% get closer to that from 12p, and if by end of year it picks up, I could well turn it around and invest in a company I trust in its management with my investment in tact.
I could do the whole coming on complaining about who is to blame, but I don't think like that, I chart my path out of risk and have patience to put a plan together once I see the picture in front of me .
It's been a long what's it now, 8 months? 9 maybe.
Now I know where I stand, and a strategy on place this goes titttsss up
A decent review
Hi All
Jesus - alot of posts for a friday night.
My Take.
Its does seem a big liberty to take out 9p Options after the uck fup of a placing @9p, however at least its at 9p - seen AIM CEOs do it at 0p , so this has been mutually agreed with largerSH imo .
I get the point of snout and trough and fully agree, but does it make me want to run for the hills? ..eerrr not really.
Firstly if, OBD never reaches 9p it might as well be a billion shares in the option, never get used anyway
Then My spidy senses think.
Why Now
future Buyout / merger - all options irrspective of date would be settled as part of any buyout, the £1mil would be needed for 1 second
Exit Plan - First time JB over emphasized his age , Partners etc
Progress - everything now on the table - I think things are now moving (others may not) but if they were now would be the time.
Its a conudrum - Have seen the senario of big options followed by a buyout 6 months later - "Ohh that was why" !! but also seen them go to nothing, never used.
For JB at worst its a risk free punt @9p - no need to buy, but the option to do so when its profitable .. Better to run an AIM thanF invest in one TBH.. but doesnt normally equate to bad news , worst case for SH if they are exersized, we are diuted - proably at a significant profit from the current SP, or the options eventually expire (and JB grants himself new ones)
One thing we can be sure of is that its in JB's self interest
Started: Dustyslay, 23 Jun 2024 11:15
Last post: Kong1, 23 Jun 2024 19:16
It is a serious joke when they announce 48% increase in revenue when it equates to only £107,000
Started: Kingalf, 21 Jun 2024 19:43
Last post: Kingalf, 21 Jun 2024 19:43
If it gets worse we could always sue.
US shareholder lawsuits have led to billions of dollars in payouts. Now investors stung by UK stock price drops are increasingly turning to litigation.
Institutional investors in Serco this week reached a settlement with the outsourcing company over a contract overcharging scandal that prompted a plunge in its shares, in the first case of its kind to go to trial in England.
Similar lawsuits are piling up in the High Court against other London-listed companies including Glencore, Standard Chartered and Barclays.
Keith Thomas, head of securities litigation at law firm Stewarts, said such cases had accelerated as a result of investors’ desire to “hold companies to account” for “egregious governance failures”
Started: Kingalf, 21 Jun 2024 16:12
Last post: Kong1, 21 Jun 2024 18:43
How can you believe what Burrows says when something like this happens.
Huge wages
Bonuses
And share incentives
The man is milking this for all it’s worth. It’s a total disgrace and a huge slap in the face for shareholders that have bought shares with their hard earned wages, to be lied to and mislead the markets.
The nomads are not much better by letting this happen
Shame on you.
Ha ha ha
Utterly unbelievable!
Burrows is useless at 'driving' the company. It has tabked under his so-called leadership.... now he gives himself 3% of the market shares and for what?
I got out of this share sometime back as it was clear what was happening. I only had it on my Watchlist so I could be 'amused' at the BODs inifference and downright immoral tactics.
So it's finally time to resign Burrows to the dark pages of the filure bin.
The only winner here is Burrows. What ever happens he keeps sucking his over-inflated salary yer-on-year. Likewise giving himself massive blocks of iotions is a win-in-win. No capital loss and all potential profit.
I hope this somehow does make PIs some profit, but there are times when you dump a company for good.
Good luck to those seeking something from this. Rhere are so many more opportunities here to give better odds.
Try TRX.l..... year on year consistent 20% growth, expansion plans always bearing fruit and a damned good BOD. It's heading towards decent profitability and worth considering.
Yes I have shares in them but its not a 'pump' its simply giving those who are not aware of them what I think is a decent, honet tip.
Bye bye to this board CIAO
Total joke, but they obviously see 9p as a target, and my average is 12p, so that 5.2p buy has paid dividends there, my one and only top up since the disaster, tiny but extra from me, I could probably recoup 90% this investment back.
All things considered, I'll take that
And of course it's like having a free bet at Ladbrokes getting warrant options, no upfront money required, can cancel them any time if above market prices, can exercise by simply taking the options and then selling using the cash generated to pay for them. Some will say that these things incentivise management....maybe that's what they were originally designed for but back in the day CEOs did not earn the kind of salary and bonus packages they get today. Now they are a freebie which can pay off very nicely just for doing your job.
Also seems a bit lob sided when Burrows gets virtually all the option shares and hardly any left ever for anyone else......
10,665,020 options over its ordinary shares of 1 pence each ("Ordinary Shares"), to certain Group employees,
10,150,020 options to Chief Executive Officer, Dr Jon Burrows
Started: Reserved, 18 Jun 2024 15:12
Last post: Newuncle, 21 Jun 2024 14:10
Btw please don't feel the need to empathise with me on my previous situation, all clear for 6 years now so all good thanks to a skilled surgeon and amazing robotic technology via the NHS
Well Dusty at risk of breaking my purdah here, there is an old saying that came to mind with OBD's delivery performance here (the product/science I aint got an issues with or the potential markets etc plus the extreme good they could do in the process for men with suspected PC or a family history of PC as I have been there, has the biopsy and the surgery that save my life in the end).
No one wanted PSE Test to be widely available more than me as I remember the day the specialist told my biopsy grades were 4/5 and 5/5 which is virtually a death sentence and I would not wish that experience on any one ever.
You can't put lipstick on a pig where OBD's commercial nounce is concerned, no matter what other numbers are used to dress them up. You may be waiting a while for some really good news here but I am sure Burrows will want to feed something to the market whenever he can.
Sorry new uncle, but it's just sounding off which I cba hearing at this point, months of it
🤐
No s h i t sherlock
Started: GIVMESUNSHINE, 19 Jun 2024 14:10
Last post: GIVMESUNSHINE, 19 Jun 2024 14:10
I know in coming across over positive - thats not the case - big there was some big thing in that presentation - One thing almost totally overlooked on here from yesterday CIRRT - £9million Grant funded, with a pretty urgent timeline IMO
OBD down to the last 2 on the shortlist, the only applicant with a test Cirt ready to use? This process started in Jan24,
Next Steps
Final meeting 26th -27th June 23
Funding July23
Project Start August 2024
https://www.ukri.org/opportunity/cancer-immunotherapy-response-research-platform/
This is really big news (if they get it) but if they dont , i'm not sure who will. all the talk about transform - this one is very relevant - Ive read all of the Cirrt page and scope documents - it fits like cinderellas shoe (on cinderella😊)
Last post: Kingalf, 18 Jun 2024 20:56
As everyone has alluded to already, the cash calls will wipe out existing shareholders. You either stay in the game by keep adding more funds on each cash call or your only hope is some kind of merger or partnership deal.
Cash burn has to be at these levels. We need credible people and they are expensive. We also need our own labs if we are to be taken seriously. It takes time for new ways of doing things to be adopted by medical professionals who don’t want to be sued, if it all goes wrong. We are still in the foothills of commercialisation and it simply is not reasonable to shout like we should be any further on. We can argue until the cows come home if previous announcements were accurate and if Burrow’s over-reached. Given the regulators are not making a fuss, I can only assume that no one on here ever made an actual complaint or if they did, it was not upheld. No one likes to be in the red, but remember this: we are invested in a company that will rocket if just one US hospital group adopts the PSE test.
Put it in the bottom drawer and come back for sales update. Anything more will just give you an unnecessary ulcer.
Started: xxProInvestorxx, 18 Jun 2024 09:47
Last post: Dustyslay, 18 Jun 2024 15:23
Sorry you miss my meaning, my avg is 12p now, from 32p, buying low 5.2p.
All I'm looking for us for it to eat into that loss short term so I can get out recuperate as much as possible
Clearly OBD can't fund itself in the near term via sales, so it's all about spending cash raised to keep the business alive, pretty shocking really. Burn rate is frightening and means another cash raise will be needed before year end imo
Unfortunately Dusty, this is extremely unlikely to hit 12p any time soon, if ever. While there has been a little recovery after the initial large drop this morning, I expect the overall trend over the next few weeks/months to continue downwards. The Bod have outlined the need for additional funding within the next year and with the share price likely to drift lower and lower, any raise would be highly dilutive, if they can get a placing away at all.
Sales of the test kits has been, at best, pitiful. Cash burn is crazy given where the company is, and talk of any 'deals' was pure fluff designed to get the placing away as I said at the time. Look at the Bupa deal, hardly had any effect on sales or the share price. Also look at the post from ADVFN on reaching the target of 1000 tests per month, even doing so OBD will still be haemorrhaging significant amounts of cash, they need thousands of sales per month to merely break even.
To see any sustained rise in the share price, significant positive news would have to be released, and given where the company are, this is extremely unlikely. Sales would need to increase ten-fold as a minimum or a large pharma licencing deal struck with actual financial payments. Also note the broker report published below, pretty bleak outlook for a house broker who are usually overly optimistic.
Broker Coverage today:
Financial performance muted for now: OBD is still relatively early in implementing its plans to maximise the commercial potential of the EpiSwitch platform and we believe that efforts have been highly creditable given current resources. Revenues of £0.33m remain modest although we note that revenues continue to lag sales particularly with CiRT, where the majority of sales are reimbursed by US insurers. Growing sales of PSE should help redress the balance given that 19% of orders are currently cash based and the expectation is that this will increase. For the future, the sheer size and opportunity of the PSE test once successfully commercialised is the key to supporting future financial independence of the company and the company achieves its 1000 tests per month objective. Inevitably, the increased activity generally with increased lab space and additional (more experienced) sales hires as OBD seeks to optimise its commercial business model has led to increased costs and an operating loss of £6.0m. We note that the company bolstered its cash resources by raising £9.9m gross in March 2024 and we look forward to the potential for the company to secure partners for the canine cancer (EpiSwitch SCB) and colorectal cancer (EpiSwitch NST) programmes which could boost cash resources. House Stock
Wish you luck Dusty.
Last post: Kong1, 18 Jun 2024 12:37
Givemesunshine
Are you sure your figures are correct
It clearly says H1 is a £5.99m loss
That’s £1m a month !
If I’m correct and you say £10m in the bank as of April 1st
That means by aprox December 31st they will have no money in the bank.
So in theory they should be wanting a funding raise around October.
With the share price dropping the number of shares needed for a funding will impact significantly on the numbers leaving shareholder value in tatters
If those ITK believe then should be huge buys at this price.
The fundraising, announced in March 2024, of £9.9m (before fees) was a significant focus during the period. We were pleased to raise these funds to support the Company's near-term activities in what were and continue to be challenging market conditions.
Challenging market conditions....what kind of garbage statement is that? Are less men being diagnosed with or getting prostate cancer, no of course not. Facts are they still can't sell test in any volume whatsoever....because its over priced and under validated.
My 40p is a bit far off w⚓️s
I'm not buying in hope of a brighter outcome, simply putting a buzz saw to my average at 5.2p bulk, and taken advantage of a claw back to draw out as much loss as possible. From 33p to 12p, so each penny contributes a massive difference to my loss, then I'm off.
Started: tahmass, 18 Jun 2024 11:06
Last post: Dustyslay, 18 Jun 2024 11:17
Man, trying to see the light through the complete darkness here!!! And you just took my flash light!!! Ssshhhhh
There are large sales even at such low price .
This will drop to below 4p within 2 weeks .
I bought at 35 pence so no point of selling as have lost near 80% already .
Started: Mekas, 18 Jun 2024 09:48
Last post: Mekas, 18 Jun 2024 09:48
Apart from all the things to put you off, what puts me off slightly is that I feel Jon Burrows earnings for 2023 (336K + 200K bonus) being over the companies revenue for the year, seems a little bit overly generous to me.
Last post: sitiain, 18 Jun 2024 07:51
Dipped my toe again here last month due to the tech . It’s hopeless
They need a complete revamp
More cash
New board
Why do I bother with AIM
They will need money again come the new year and what is going to change . 🤷♂️The prostrate test is the only chance and they can’t sell any . Need a big swinging divk in charge . They won’t be able to attract one . Best sell tech to pharma because they will be picking not up for pennies soon as it goes bust
Started: DugWalker, 18 Jun 2024 07:50
Last post: DugWalker, 18 Jun 2024 07:50
Seems the staffer that halted that by going on holiday hadn't returned yet.
When they inevitably launch another test in a few months time I hope it identifies biomarkers indicative of commercial nouse. I'd personally buy one of those for the entire senior management team and make a significant contribution to boosting sales in the process.
Last post: Dustyslay, 18 Jun 2024 07:17
This may be acceptance day
Surely all the positive RNS released over the last few weeks wasn't an elaborate ploy to talk the shares up for friends to off load. Slightly cynical I know but you never know with this lot. Still we don't have to wait long to get a true indication of what is actually happening.
Started: Amica1, 11 Jun 2024 18:59
Last post: Amica1, 11 Jun 2024 18:59
I read this BB from time to time as the product seemed good but the company useless in every way.
I still recommend W7L as it's just going from strength to strength - best run Co. on AIM many say.
If like me you lost money on OBD, you can make it up on this. Investors show tomorrow.
Started: worst, 6 Jun 2024 07:36
Last post: Dustyslay, 11 Jun 2024 15:33
I've said it in the past, it's all about traction.
Marketing it, getting it used in as many areas as possible until it becomes highly sought after.
And that would never take a few months
IMO cashflow isnt the key thing here at the moment - lack of uptake / growth with a high cash burn is the issue - investor will happily fund growth stories with a plan that is delivered to, last results showed that plan had at best "stuttered". and we voted with our feet..looking at the net cash used They are fundend to March -April 2025 imo as Cirt reveunes and PSE to an extent are delayed and without any growth from here should ad $1.5 million on top of research, PACTand Tax credit
this finacail year, lab cost capex is now sunk, but we have additional senior staff . so hard to tell - but any uplift in revenue will make a big difference
There cash flow is a problem, but man what a product. We have to give this time, I've always been in that mindset once I knew the sales was low, and I've not topped up once on the way down until this bottom has presented itself, I expect a potential placing and will see what that price entails and I will buy cheap shares on better news
True - TBF this was on made "avaiable" at the end of september, US code 5 months ago, and UK Lab 2 months ago - I think it imprtant to not get ahead , but i dont myself think those timeline are very long in this sector . They must have been talking to TLC for some time to be able reach that point so soon after UK Lab
But they do have too many irons in fires without enough fuel to keep em all going without growth so its an important year
It's the old adage really, the longer you hold a stock, the less risk it becomes. Hold this long enough, these things will improve over time. Too many oncology companies fighting for a slice in this market, a lot of products ranging from medication, testing to end of life.
I think that should have been put on the packet, to say it would fly off the shelf was a crime in itself, but there over confidence is a positive, as it will eventually become apparent it's as good as its written on paper after being in circulation 12 months
Started: Kingalf, 6 Jun 2024 14:18
Last post: Kingalf, 6 Jun 2024 14:18
Unless we get a massive order, participate in a major trail or there is a bid, I just can't see these going up. All the positive news just allows the bears to off load. 01234 you are more than likely right.
Started: Pensioninvestor, 6 Jun 2024 08:32
Last post: 01234, 6 Jun 2024 11:31
The market is telling you everything you need to know. It’s positive good news but it also means not only will sales be way off but also the product still needs validation . Cash raise is now nailed on here so wait and see where that settles . IMHO
If we could just get to the 10 p mark it would be some good news.
The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. Established under the National Cancer Institute Act of 1937, NCI is part of the National Institutes of Health (NIH), one of 11 agencies that make up the Department of Health and Human Services (HHS).
Started: Waynesmith, 5 Jun 2024 09:00
Last post: Kong1, 6 Jun 2024 07:31
5 years to wait before results
Mmmmmm, not sure the company will make another 5 years.
That is great news…but you’ve literally spelt out it won’t make any money for 5 years
I'd put Dug in charge, he seems to know the ins and outs of the company's failings, can maybe get things moving. Do a rolls royce, ceo boost
Best news would be seeing Burrows and FD resign
Need some very good news now